IL200862A0 - 3-imidazolyl-indoles for the treatment of proliferative diseases - Google Patents

3-imidazolyl-indoles for the treatment of proliferative diseases

Info

Publication number: IL200862A0
Authority: IL; Israel
Prior art keywords: indoles; imidazolyl; treatment; proliferative diseases; proliferative
Prior art date: 2007-03-29

Application number

IL200862A

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-29

Filing date

2009-09-10

Publication date

2010-05-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38328915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL200862(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-09-10 Application filed by Novartis Ag filed Critical Novartis Ag

2010-05-17 Publication of IL200862A0 publication Critical patent/IL200862A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL200862A 2007-03-29 2009-09-10 3-imidazolyl-indoles for the treatment of proliferative diseases IL200862A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07105269		2007-03-29
PCT/EP2008/053667 WO2008119741A2 (en)	2007-03-29	2008-03-27	3-imidazolyl-indoles for the treatment of proliferative diseases

Publications (1)

Publication Number	Publication Date
IL200862A0 true IL200862A0 (en)	2010-05-17

Family

ID=38328915

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL200862A IL200862A0 (en)	2007-03-29	2009-09-10	3-imidazolyl-indoles for the treatment of proliferative diseases

Country Status (27)

Country	Link
US (1)	US8053457B2 (en)
EP (1)	EP2142535A2 (en)
JP (1)	JP2010522723A (en)
KR (1)	KR20090122403A (en)
CN (1)	CN101679382A (en)
AR (1)	AR065860A1 (en)
AU (1)	AU2008234954B9 (en)
BR (1)	BRPI0810082A2 (en)
CA (1)	CA2682483A1 (en)
CL (1)	CL2008000899A1 (en)
CR (1)	CR11019A (en)
DO (1)	DOP2009000229A (en)
EA (1)	EA200901212A1 (en)
EC (1)	ECSP099660A (en)
GT (1)	GT200900256A (en)
IL (1)	IL200862A0 (en)
MA (1)	MA31260B1 (en)
MX (1)	MX2009010413A (en)
NI (1)	NI200900177A (en)
PA (1)	PA8774001A1 (en)
PE (1)	PE20081897A1 (en)
SM (1)	SMP200900085B (en)
TN (1)	TN2009000388A1 (en)
TW (1)	TW200843746A (en)
UY (1)	UY30987A1 (en)
WO (1)	WO2008119741A2 (en)
ZA (1)	ZA200906210B (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2007235578B2 (en) *	2006-04-07	2011-07-14	Janssen Pharmaceutica N.V.	Indoles and benzoimidazoles as modulators of the histamine H4 receptor
AR070398A1 (en)	2008-02-22	2010-03-31	Gruenenthal Chemie	INDOL SUBSTITUTED DERIVATIVES
US20100035862A1 (en) *	2008-06-25	2010-02-11	Abbott Laboratories	Novel aza-cyclic indole-2-carboxamides and methods of use thereof
MX353900B (en)	2008-11-07	2018-02-01	Massachusetts Inst Technology	Aminoalcohol lipidoids and uses thereof.
CN102356085A (en) *	2009-01-16	2012-02-15	第一三共株式会社	Imidazothiazole derivative having proline ring structure
JP2012102017A (en) *	2009-03-03	2012-05-31	Astellas Pharma Inc	Indole compound
US20120028990A1 (en) *	2009-04-16	2012-02-02	Msd K.K	3 aryl or heteroaryl-substituted indole derivative
AU2010319595B2 (en)	2009-11-12	2015-09-17	The Regents Of The University Of Michigan	Spiro-oxindole MDM2 antagonists
WO2011106650A2 (en) *	2010-02-27	2011-09-01	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
JO2998B1 (en) *	2010-06-04	2016-09-05	Amgen Inc	Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
AU2011299551A1 (en) *	2010-09-08	2013-03-21	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	P53-Mdm2 antagonists
FR2967072B1 (en)	2010-11-05	2013-03-29	Univ Dundee	PROCESS FOR IMPROVING INFLUENZA PRODUCTION OF VACCINE AND SEEDS
JP2014500870A (en)	2010-11-12	2014-01-16	ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン	Spiro-oxindole MDM2 antagonist
US20120202794A1 (en) *	2011-01-24	2012-08-09	Pharmasset, Inc.	Compounds
CA2829188C (en)	2011-03-10	2016-10-18	Daiichi Sankyo Company, Limited	Dispiropyrrolidine derivatives
DK2691443T3 (en)	2011-03-28	2021-05-03	Massachusetts Inst Technology	CONJUGIATED LIPOMERS AND USES OF THESE
CN102702066A (en) *	2011-03-28	2012-10-03	苏州百灵威超精细材料有限公司	Novel method for preparing intermediate 6-chloro-5-fluoroindole used for synthesizing anticancer and weight-reducing medicine
ES2624808T3 (en)	2011-05-11	2017-07-17	The Regents Of The University Of Michigan	MDM2 spirooxindol antagonists
WO2012177927A1 (en)	2011-06-21	2012-12-27	Mayo Foundation For Medical Education And Research	Transgenic animals capable of being induced to delete senescent cells
WO2012176123A1 (en) *	2011-06-22	2012-12-27	Novartis Ag	3 - imidazolyl- indoles for the treatment of proliferative diseases
US9408885B2 (en)	2011-12-01	2016-08-09	Vib Vzw	Combinations of therapeutic agents for treating melanoma
US20140335074A1 (en)	2011-12-13	2014-11-13	Buck Institute For Research On Aging	Methods for improving medical therapies
WO2013158664A2 (en)	2012-04-17	2013-10-24	Kythera Biopharmaceuticals, Inc.	Use of engineered viruses to specifically kill senescent cells
CA2884870C (en)	2012-08-13	2022-03-29	Massachusetts Institute Of Technology	Amine-containing lipidoids and uses thereof
US9901080B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse for determining the role of senescent cells in cancer
TWI586668B (en)	2012-09-06	2017-06-11	第一三共股份有限公司	Crystals of dispiropyrrolidine derivative
TW201429969A (en)	2012-12-20	2014-08-01	Merck Sharp & Dohme	Substituted imidazolium as an HDM2 inhibitor
WO2014179562A1 (en)	2013-05-01	2014-11-06	Massachusetts Institute Of Technology	1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
EP3669881B1 (en)	2014-01-28	2022-03-30	Buck Institute for Research on Aging	Compositions for use in the treatment of senescence-assiocated eye disease and disorders
WO2015116735A1 (en)	2014-01-28	2015-08-06	Mayo Foundation For Medical Education And Research	Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders
EP3139942B1 (en)	2014-05-05	2019-12-18	Bioventures, Llc	COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS
US9840479B2 (en)	2014-07-02	2017-12-12	Massachusetts Institute Of Technology	Polyamine-fatty acid derived lipidoids and uses thereof
JP6503386B2 (en)	2014-07-03	2019-04-17	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Novel spiro [3H-indol-3,2'-pyrrolidine] -2 (1H) -one compounds and derivatives as MDM2-p53 inhibitors
US10071087B2 (en)	2014-07-22	2018-09-11	Bioventures, Llc	Compositions and methods for selectively depleting senescent cells
KR20170042779A (en)	2014-08-21	2017-04-19	베링거 인겔하임 인터내셔날 게엠베하	New spiro[3h-indole-3,2'-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
US20180006236A1 (en)	2014-12-26	2018-01-04	Dow Global Technologies Llc	Organic compounds and electronic device comprising organic layer comprising organic compounds
CA2976752C (en)	2015-02-20	2019-12-17	Daiichi Sankyo Company, Limited	Method for treating cancer by combined use
TWI697329B (en)	2015-04-13	2020-07-01	日商第一三共股份有限公司	Medicament for use in the treatment of a hematological cancer and use thereof
WO2016207089A1 (en)	2015-06-22	2016-12-29	Bayer Pharma Aktiengesellschaft	Antibody drug conjugates (adcs) and antibody prodrug conjugates (apdcs) with enzymatically cleavable groups
JOP20160198B1 (en) *	2015-09-16	2022-03-14	Janssen Pharmaceuticals Inc	Single or di-substituted indole derivatives as inhibitors of viral replication of fennel fever
PL3359542T3 (en)	2015-10-09	2021-09-20	Boehringer Ingelheim International Gmbh	COMPOUNDS AND DERIVATIVES SPIRO [3H-INDOLO-3,2′-PYROLIDINE] -2 (1H) -ONE AS MDM2-P53 INHIBITORS
US10759808B2 (en)	2016-04-06	2020-09-01	The Regents Of The University Of Michigan	Monofunctional intermediates for ligand-dependent target protein degradation
CN109415336B (en)	2016-04-06	2023-08-29	密执安大学评议会	MDM2 protein degrader
JP6936498B2 (en)	2016-04-21	2021-09-15	バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ，ＬＬＣ	Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and their use
CN105906610B (en) *	2016-05-24	2018-10-23	绍兴文理学院	A kind of 3-（4- phenyl -1H- imidazoles -5- bases）- 1H- indole derivatives and its preparation method and application
PT3272745T (en) *	2016-07-21	2019-09-27	Inst Farmakologii Polskiej Akademii Nauk	Imidazolyl-substituted indole derivatives binding 5-ht7 serotonin receptor and pharmaceutical compositions thereof
KR20190068544A (en)	2016-10-17	2019-06-18	다이이찌 산쿄 가부시키가이샤	Combination treatment of MDM2 inhibitor with DNA methyltransferase inhibitor
TW201831477A (en)	2016-11-28	2018-09-01	瑞士商赫孚孟拉羅股份公司	Oxadiazolone transient receptor potential channel inhibitors
WO2018114578A1 (en)	2016-12-21	2018-06-28	Bayer Pharma Aktiengesellschaft	Antibody drug conjugates (adcs) having enzymatically cleavable groups
CN110461838B (en)	2017-03-07	2022-05-06	豪夫迈·罗氏有限公司	Oxadiazole Transient Receptor Potential Channel Inhibitors
BR112019021032A2 (en)	2017-04-05	2020-05-05	Boehringer Ingelheim International Gmbh	anticancer combination therapy
JOP20190245A1 (en)	2017-04-20	2019-10-15	Novartis Ag	Sustained release delivery systems comprising traceless linkers
EP3630109A4 (en) *	2017-05-26	2021-03-17	Rutgers, the State University of New Jersey	Bacterial efflux pump inhibitors
JP7385284B2 (en)	2018-01-22	2023-11-22	バイオベンチャーズ・リミテッド・ライアビリティ・カンパニー	BCL-2 proteolytic agents for cancer treatment
US10710994B2 (en)	2018-03-19	2020-07-14	Genentech, Inc.	Oxadiazole transient receptor potential channel inhibitors
WO2019221755A1 (en)	2018-05-18	2019-11-21	Bioventures, Llc	Piperlongumine analogues and uses thereof
AR116566A1 (en)	2018-10-03	2021-05-19	Novartis Ag	SUSTAINED ADMINISTRATION OF ANGIOPOYETIN-SIMILAR POLIPEPTIDES 3
US12281099B2 (en) *	2019-02-26	2025-04-22	Boehringer Ingelheim International Gmbh	Isoindolinone substituted indoles and derivatives as RAS inhibitors
US12186401B2 (en)	2019-03-01	2025-01-07	Ontario Institute for Cancer Research (OICR) and Sinai Health System	Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) and associated uses
WO2022137085A1 (en) *	2020-12-22	2022-06-30	Novartis Ag	Indole derivatives useful in treating conditions associated with cgas
WO2022204235A1 (en) *	2021-03-23	2022-09-29	Nido Biosciences, Inc.	Bicyclic compounds as androgen receptor modulators
CN117510416A (en) *	2023-11-06	2024-02-06	浙江普洛康裕制药有限公司	A kind of preparation method of (2R,5S)-4-Boc-2,5-dimethylpiperazine
PL447976A1 (en) *	2024-03-11	2025-09-15	Celon Pharma Spółka Akcyjna	An imidazole-indole derivative that binds to the 5-HT7 serotonin receptor, a pharmaceutical composition containing the derivative, uses of the derivative and the composition, and an intermediate for preparing the imidazole-indole derivative
WO2025231011A1 (en) *	2024-05-01	2025-11-06	Omniab, Inc.	Heteroarylindole inhibitors of apol-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19948417A1 (en) *	1999-10-07	2001-04-19	Morphochem Ag	Imidazole derivatives and their use as medicines
JP2002114780A (en) *	2000-10-11	2002-04-16	Taisho Pharmaceut Co Ltd	4-(3-indolyl)imidazole derivative
CA2752738C (en)	2005-02-22	2014-05-27	The Regents Of The University Of Michigan	Small molecule inhibitors of mdm2 and uses thereof
US7576082B2 (en)	2005-06-24	2009-08-18	Hoffman-La Roche Inc.	Oxindole derivatives

2008
- 2008-03-27 KR KR1020097022526A patent/KR20090122403A/en not_active Withdrawn
- 2008-03-27 BR BRPI0810082-9A2A patent/BRPI0810082A2/en not_active IP Right Cessation
- 2008-03-27 CA CA002682483A patent/CA2682483A1/en not_active Abandoned
- 2008-03-27 CN CN200880017611A patent/CN101679382A/en active Pending
- 2008-03-27 MX MX2009010413A patent/MX2009010413A/en not_active Application Discontinuation
- 2008-03-27 JP JP2010500280A patent/JP2010522723A/en active Pending
- 2008-03-27 EA EA200901212A patent/EA200901212A1/en unknown
- 2008-03-27 US US12/593,721 patent/US8053457B2/en not_active Expired - Fee Related
- 2008-03-27 AU AU2008234954A patent/AU2008234954B9/en not_active Ceased
- 2008-03-27 AR ARP080101262A patent/AR065860A1/en unknown
- 2008-03-27 PE PE2008000554A patent/PE20081897A1/en not_active Application Discontinuation
- 2008-03-27 WO PCT/EP2008/053667 patent/WO2008119741A2/en not_active Ceased
- 2008-03-27 EP EP08735532A patent/EP2142535A2/en not_active Withdrawn
- 2008-03-28 UY UY30987A patent/UY30987A1/en not_active Application Discontinuation
- 2008-03-28 PA PA20088774001A patent/PA8774001A1/en unknown
- 2008-03-28 CL CL2008000899A patent/CL2008000899A1/en unknown
- 2008-03-28 TW TW097111568A patent/TW200843746A/en unknown
2009
- 2009-09-08 ZA ZA200906210A patent/ZA200906210B/en unknown
- 2009-09-09 CR CR11019A patent/CR11019A/en unknown
- 2009-09-10 IL IL200862A patent/IL200862A0/en unknown
- 2009-09-24 TN TNP2009000388A patent/TN2009000388A1/en unknown
- 2009-09-24 MA MA32230A patent/MA31260B1/en unknown
- 2009-09-28 DO DO2009000229A patent/DOP2009000229A/en unknown
- 2009-09-28 NI NI200900177A patent/NI200900177A/en unknown
- 2009-09-28 GT GT200900256A patent/GT200900256A/en unknown
- 2009-09-29 EC EC2009009660A patent/ECSP099660A/en unknown
- 2009-10-28 SM SM200900085T patent/SMP200900085B/en unknown

Also Published As

Publication number	Publication date
WO2008119741A3 (en)	2008-12-04
MA31260B1 (en)	2010-03-01
CN101679382A (en)	2010-03-24
US20100125064A1 (en)	2010-05-20
PA8774001A1 (en)	2008-11-19
DOP2009000229A (en)	2009-10-31
SMP200900085B (en)	2010-11-12
ZA200906210B (en)	2010-05-26
JP2010522723A (en)	2010-07-08
MX2009010413A (en)	2009-10-20
TN2009000388A1 (en)	2010-12-31
KR20090122403A (en)	2009-11-27
EP2142535A2 (en)	2010-01-13
TW200843746A (en)	2008-11-16
WO2008119741A2 (en)	2008-10-09
CA2682483A1 (en)	2008-10-09
CL2008000899A1 (en)	2009-02-20
AU2008234954B9 (en)	2012-02-02
AU2008234954B2 (en)	2011-10-27
ECSP099660A (en)	2009-10-30
US8053457B2 (en)	2011-11-08
UY30987A1 (en)	2008-10-31
AU2008234954A1 (en)	2008-10-09
AR065860A1 (en)	2009-07-08
CR11019A (en)	2009-10-20
BRPI0810082A2 (en)	2014-10-21
EA200901212A1 (en)	2010-04-30
GT200900256A (en)	2010-03-15
SMAP200900085A (en)	2010-01-19
PE20081897A1 (en)	2009-02-09
NI200900177A (en)	2010-09-09

Publication	Publication Date	Title
ZA200906210B (en)	2010-05-26	3-Imidazolyl-Indoles for the treatment of proliferative diseases
SI2001892T1 (en)	2013-07-31	Imidazolothiazole compounds for the treatment of proliferative diseases
ZA201000106B (en)	2011-06-29	Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
ZA201000087B (en)	2011-06-29	Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
IL211985A0 (en)	2011-06-30	Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
PL2303021T3 (en)	2019-10-31	Compounds for the treatment of cancer
ZA201001304B (en)	2013-08-28	Compositions for the treatment of neoplastic diseases
ZA200707591B (en)	2009-08-26	Dihyrothienopyrimidines for the treatment of inflammatory diseases
EP2063897A4 (en)	2010-09-29	Kinase inhibitors useful for the treatment of proliferative diseases
EP2063896A4 (en)	2010-09-29	Kinase inhibitors useful for the treatment of proliferative diseases
ZA201100534B (en)	2011-10-26	Triazole derivatives useful for the treatment of diseases
EP2178370A4 (en)	2011-01-12	Combinations for the treatment of b-cell proliferative disorders
ZA200906129B (en)	2010-11-24	Compounds for the treatment of hepatitis c
IL208357A0 (en)	2010-12-30	Spiro-indole derivatives for the treatment of parasitic diseases
IL218283A0 (en)	2012-04-30	Combination therapy for treating proliferative diseases
IL204728A0 (en)	2010-11-30	Methods and compounds for treating retinol-related diseases
SI2209784T1 (en)	2013-02-28	Compounds for the treatment of hepatitis c
ZA201003425B (en)	2011-04-28	5-cyano-thienopyridines for the treatment of tumors
IL201449A0 (en)	2010-05-31	Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
GB0906159D0 (en)	2009-05-20	Drug combination for the treatment of proteostatic diseases
GB0715790D0 (en)	2007-09-26	Drug combination for the treatment of sialorrhoea
IL210066A0 (en)	2011-02-28	Novel ortho-aminoanilides for the treatment of cancer
IL205339A0 (en)	2010-12-30	Compounds and methods for the treatment of cancer
HK1137996A (en)	2010-08-13	3-imidazolyl-indoles for the treatment of proliferative diseases
GB0715255D0 (en)	2007-09-12	Thiadiazol-piperazinyl derivatives for the treatment of neurodegenerative diseases